I used to own GLPG but I have not followed it closely after I sold it in the 60s. I was disappointed at the low royalty rate for filgotinib in RA and CF with Abbvie. I think they get a better deal in RA with GILD after Abbvie dropped filgotinib in RA but I am not sure. FWIW
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.